摘要
抵抗素最初被认为是联系肥胖、胰岛素抵抗和2型糖尿病的新型脂肪细胞因子。但随后的研究发现抵抗素在人体主要参与炎症和免疫反应。动脉粥样硬化是一种慢性炎症性过程,体外研究提示抵抗素可能参与动脉粥样硬化的发生发展。本文就抵抗素参与动脉粥样硬化的具体机制作一综述。
出处
《中国分子心脏病学杂志》
CAS
2007年第3期167-169,共3页
Molecular Cardiology of China
参考文献25
-
1[1]Steppan CM,Bailey ST,Bhat S,et al.The hormone resistin links obesity to diabetes.Nature,2001,409 (6818):307-12.
-
2[2]Patel L,Buckels AC,Kinghorn IJ,et al.Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators,Biochem.Biophys.Res.Commun,2003,300:472-476.
-
3[3]Kaser S,Kaser A,Sandhofer A,et al.Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro.Biochem.Biophys.Res.Commun,2003,309:286-290.
-
4[4]Lu SC,Shieh WY,Chen CY,et al.Lipopolysaccharide increases resistin gene expression in vivo and in vitro.FEBS.Lett,2002,530:158-162.
-
5[5]Lehrke M,Reilly MP,Millington SC,et al.An inflammatory cascade leading to hyperresistinemia in humans.PLoS.Med,2004,1(2):161-168.
-
6[6]Silswal N,Singh AK,Aruna B,et al.Human resistin stimulates the pro-inflammatory cytokines TNF-α and IL-12 in macrophages by NF-κB-dependent pathway.Biochem.Biophys.Res.Commun,2005,334:1092-1101.
-
7[7]Bokarewa M,Nagaev I,Dahlberg L,et al.Resistin,an adipokine with potent proinflammatory properties.J.Immunol,2005,174:5789-5795.
-
8[8]Ross R..Atherosclerosis-An Inflammatory Disease.N Engl Med J,1999,340:115-126.
-
9[9]Xu W,Yu L,Zhou W,et al.Resistin increases lipid accumulation and CD36 expression in human macrophages.Biochem Biophys Res Commun,2006; 351 (2):376-82.
-
10[10]Kawanami D,Maemura K,Takeda N,et al.Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells:a new insight into adipocytokine-endothelial cell interactions.Biochem Biophys Res Commun,2004,314(2):415-9.
同被引文献27
-
1夏青.氨氯地平的药理和临床应用[J].中外医疗,2008,27(25):86-87. 被引量:15
-
2陈阳,俞建昆,褚嘉祐.抵抗素的研究进展[J].国外医学(内分泌学分册),2005,25(4):243-245. 被引量:2
-
3朱晓云,朱继金.他汀类非调脂作用在稳定急性冠脉综合征病变斑块的机制[J].心血管病学进展,2005,26(B08):1-3. 被引量:5
-
4赵水平.代谢综合征的处理.心脏病学实践2004-规范化治疗[M].北京:人民卫生出版社,2004:621-629.
-
5Expert Panel on Detection, Evalution, Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program(NCEP) expert panel on detection, evalution, and treatment of high blood cholesterol in adults( Adults Treatment Panel Ⅲ) [ J ]. JAMA,2001,285 : 2486 -2497.
-
6Bunett MS, Lee CW, Kirmaird TD, et al. The potential role of resislin in atherogenesis [ J ]. Atherosclerosis ,2005,182 (2) : 241 - 248.
-
7Lubos E, Messow CM, Schnabel R, et al. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study[J]. Atherosclerosis,2007,193 ( 1 ) : 121 - 128.
-
8Mian ST, Shu YC, Dao MC, et al. Association of resistin gene 3' - un- translated region + 62GA polymorphism with type 2 diabetes and hypertension in a Chinese population [ J ]. J Clin Endocrinol Metab,2003, 88 : 1258 - 1263.
-
9Mattcvi VS, Zembrzuski VM, Hutz MH, et al. A resistin gcne polymorphism is associated with body mass index in women[ J]. Hum Genet,2004,115 : 208 -212.
-
10Bajaj M, Suraamornkul S, Hardies LJ, et al. Plasmae rsistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglita zone- terated type Ⅱ diabetic patients [ J ]. Int J Obes Relat Metab Disord, 2004, 28:783 -789.
引证文献3
-
1胡天勇,刘鹏,关怀敏,解金红,王枫岭,李靖,赵杰娉,张燕,陈玉善,张辉,李刚,李莉,罗明华.代谢综合征患者干预治疗后血清抵抗素的动态变化及其影响因素的研究[J].中国卫生检验杂志,2009,19(5):1064-1065.
-
2刘新华,王福荣,于俊生.从抵抗素与微炎症状态的关系探讨慢性肾衰竭的中医药辨证施治[J].世界中西医结合杂志,2011,6(11):1010-1012. 被引量:5
-
3王琪,程燕玲,申建民,董媛媛.苯磺酸氨氯地平对动脉粥样硬化性脑梗死患者抵抗素水平及颈动脉内膜的影响[J].山西医药杂志(下半月),2012,41(4):370-371. 被引量:5
二级引证文献10
-
1高少琳,于荣.奥美沙坦联合苯磺酸氨氯地平治疗原发性高血压的临床观察[J].中国药物与临床,2012,12(11):1495-1496. 被引量:7
-
2夏幼林,夏新红.奥美沙坦联合苯磺酸氨氯地平治疗原发性高血压的临床观察[J].中国药房,2014,25(4):353-355. 被引量:4
-
3张小琴,彭学清.奥美沙坦联合苯磺酸氨氯地平治疗原发性高血压的临床观察[J].山西医药杂志,2014,43(8):858-860. 被引量:5
-
4包娅琼,刘家生.中医对慢性肾脏病营养不良-炎症-动脉粥样硬化综合征病因病机的认识[J].甘肃医药,2014,33(10):745-747. 被引量:5
-
5张吉.奥美沙坦酯联合氨氯地平对原发性高血压患者血压昼夜节律及变异性的影响[J].西南军医,2016,18(1):62-64. 被引量:7
-
6郭春,杜爱民,邓琬莹,朱高平,马腾,喻娇.阿托伐他汀联合苯磺酸氨氯地平治疗脑梗死的效果观察[J].中国实用神经疾病杂志,2016,19(16):16-18.
-
7韩君英,牛春兰,毛艺,陈颖.牛春兰论治营养不良-炎症-动脉粥样硬化综合征探析[J].中医药通报,2020,19(2):29-31. 被引量:1
-
8白兰,张燕,刘鹏霄,孙丽丽,张卿,徐胜珍,徐月清.中医药对慢性肾衰竭患者微炎症状态影响的研究现状[J].西部中医药,2021,34(9):150-153. 被引量:17
-
9孙鲁英,孙卫卫,周少峰,田蕾,张美龄,艾思南,郑慧娟,李垚锬,李丹婷,刘伟敬,周静威,王珍,王耀献.中医药防治慢性肾脏病的临床证据及效应机制[J].生物医学转化,2022,3(3):31-44. 被引量:17
-
10汪六林,巴元明.大黄素对UUO小鼠肾脏纤维化及炎症因子的影响[J].时珍国医国药,2022,33(10):2386-2388. 被引量:2
-
1岳华,宋书凯.冠心病患者血清高敏C-反应蛋白和β2-微球蛋白水平及其相关性研究[J].中国全科医学,2008,11(12):1047-1048. 被引量:5
-
2陈晓曦,张学东.IL-8与糖尿病视网膜病变[J].国际眼科杂志,2010,10(6):1106-1108. 被引量:2
-
3訾春雷.慢性阻塞性肺疾病并肺间质纤维化42例分析[J].中国煤炭工业医学杂志,2009,12(6):901-901. 被引量:1
-
4田浩明,梁荩忠.低密度脂蛋白过氧化的体外研究[J].中华医学杂志,1993,73(5):306-307.
-
5王阿妮,唐利龙.血尿酸与心血管疾病的发生、发展及预后关系[J].心血管病学进展,2008,29(4):606-609. 被引量:2
-
6肖明友.重症肝炎患者外周血单个核细胞对内毒素敏感性的体外研究[J].传染病信息,2002,15(2):89-90.
-
7王玲.中西医结合治疗糖尿病肾病[J].中国民族民间医药,2012,21(11):65-66.
-
8郑建明,朱明华.第四讲 慢性胰腺炎的病理[J].胰腺病学,2007,7(4):268-270. 被引量:1
-
9王晓丽,温鸿雁,李小峰,国华.类风湿关节炎肺间质病变5例临床分析[J].临床医药实践,2007,16(5):376-378.
-
10丁超,傅向华.他汀类药物的抗心律失常作用研究进展[J].医学综述,2008,14(15):2323-2327. 被引量:3